Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 1, 2001 - Issue 1
Submit an article Journal homepage
69
Views
12
CrossRef citations to date
0
Altmetric
Drug Evaluation

O-raffinose-polymerised haemoglobin. A biochemical and pharmacological profile of an oxygen carrier

Roberto Scatena Institute of Chemistry and Clinical Chemistry, Faculty of Medicine, Catholic University, Largo Francesco Vito 1, 00168 Rome, Italy. [email protected]
&
Bruno Giardina Institute of Chemistry and Clinical Chemistry, Faculty of Medicine, Catholic University, Largo Francesco Vito 1, 00168 Rome, Italy. [email protected]
Pages 121-127 | Published online: 23 Feb 2005

  • VANDEGRIFF KD: Haemoglobin-based oxygen carriers. Exp. Opin. Invest. Drugs (2000) 9:1967–1984.
  • ••An excellent review on pharmacological aspects ofhaemoglobin-based oxygen carriers.
  • CARMICHAEL FJL: Development status of hemolink (o-raffinose crosslinked human haemoglobin). Workshop on Criteria for Safety and Efficacy Evaluation of Oxygen Therapeutics as Red Cell Substitutes. Rockville, USA (1999).
  • CARON A, MENU P, FAIVRE-FIORINA B, LABRUDE P, ALAYASH Al, VIGNERON C: Cardiovascular and hemorheological effects of three modified human haemoglobin solutions in hemodiluted rabbits. J Appl. Physiol. (1999) 86:541–548.
  • ROHLFS RJ, BRUNER E, CHIU A et al: Arterial blood pressure responses to cell-free haemoglobin solutions and the reaction with nitric oxide. J Biol. Chem. (1998) 273:12128–12134.
  • LIEBERTHAL W, FUHRO R, FREEDMAN JE, TOOLAN G,LOSCALZO J, VALERI CR: 0-raffinose cross-linking markedly reduces systemic and renal vasoconstrictor effects of unmodified human haemoglobin. J. Pharmacol. Exp. Ther. (1999) 288:1278–1287.
  • BAINES AD, CHRISTOFF B, WICKS D, WIFFEN D, PLIURA D: Cross-linked haemoglobin increases fractional reabsorption and GFRin hypoxic isolated perfused rat kidneys. Am. J Physiol. (1995) 269:F628–636.
  • KERGER H, TSAI AG, SALTZMAN DJ, WINSLOW RM, INTAGLIETTA M: Fluid resuscitation with 02 vs.non-02 carriers after 2 h of hemorrhagic shock in conscious hamsters. Am. J. Physic]. (1997) 272:H525–H537.
  • LIEBERTHAL W, FUHRO R, ANDRY C, VALERI CR: Effectsof haemoglobin-based oxygen-carrying solutions in anesthetized rats with acute ischemic renal failure. J Lab. Clin. Med. (2000) 135:73–81.
  • MENU P, BLEEKER W, LONGROIS D et al.: In vivo effectsof Fib solutions on blood viscosity and rheologic behavior of RBCs: comparison with clinically used volume expanders. Transfusion (2000) 40:1095–1103.
  • CARON A, MENU P, FAIVRE-FIORINA B et al: Systemic and renal hemodynamics after moderate hemodilu-tion with HbOCs in anesthetized rabbits. Am. J. Physiol. Heart Circ. Physiol (2000) 278:H1974–1983.
  • WONG LT, ER SS, NING J, CHRISTOFF B, CARMICHAEL FJ: Hemolink-induced effects on intestinal motor function and attenuation of these effects by selected agents. Aril]: Cells Blood Substit. Immobil Biotechnoi (1998) 26:529–548.
  • XUE S, PATERSON W, VALDEZ D et al.: Effect of an o-raffinose cross-linked haemoglobin product on oesophageal and lower oesophageal sphincter motor function. Neurogastroenterol Mott]. (1999) 11:421–430.
  • FREILICH D, BRANDA R, HACKER M et al.: Decreased lactic acidosis and anemia after transfusion of o-raffinose cross-linked and polymerised haemoglobin in severe murine malaria. Am. J Trop. Med. Hyg. (1999) 60:322–328.
  • HSIA JC, SONG DL, ER SS et al: Pharmacokinetic studies in the rat on a o-raffinose polymerised human haemoglobin. Biomater. Arid: Cells Immobilization Biotechnol (1992) 20:587–595.
  • CARMICHAEL FJ, ALI AC, CAMPBELL JA et al.: A Phase I study of oxidized raffinose cross-linked human haemoglobin. Crit. Care Med. (2000) 28:2283–2292.
  • CHANG TMS: Future prospects for artificial blood. Trends Biotech. (1999) 17:61–67.
  • ••Comprehensive review of the blood substitutes.
  • GULATI A, BARVE A, SEN AP: Pharmacology of haemoglobin therapeutics. J Lab. Clin. Med. (1999) 133:112–119.
  • GIARDINA B, MESSANA I, SCATENA R, CASTAGNOLA M: The multiple functions of haemoglobin. Crit. Rev. Biochem. Biol. (1995) 30:165–196.
  • ALAYASH Al: Haemoglobin based blood substitutes: oxygen carriers, pressor agents, or oxidants? Nature Biotech. (1999) 17:545–549.
  • ••A description of toxicological aspects of HBOCs.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.